These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9076875)

  • 21. Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group.
    Versi E; Appell R; Mobley D; Patton W; Saltzstein D
    Obstet Gynecol; 2000 May; 95(5):718-21. PubMed ID: 10775736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravesical instillation of oxybutynin hydrochloride for detrusor hyper-reflexia.
    O'Flynn KJ; Thomas DG
    Br J Urol; 1993 Nov; 72(5 Pt 1):566-70. PubMed ID: 10071538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New adverse effect of oxybutynin: "night terror".
    Valsecia ME; Malgor LA; Espíndola JH; Carauni DH
    Ann Pharmacother; 1998 Apr; 32(4):506. PubMed ID: 9562151
    [No Abstract]   [Full Text] [Related]  

  • 24. Expanded followup of intravesical oxybutynin chloride use in children with neurogenic bladder.
    Kaplinsky R; Greenfield S; Wan J; Fera M
    J Urol; 1996 Aug; 156(2 Pt 2):753-6. PubMed ID: 8683776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is attempting suicide an adverse effect of oxybutynin in a child with enuresis nocturna?
    Coskun S; Yüksel H; Onag A
    Pediatr Emerg Care; 2001 Oct; 17(5):398. PubMed ID: 11673723
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury.
    Pannek J; Sommerfeld HJ; Bötel U; Senge T
    Urology; 2000 Mar; 55(3):358-62. PubMed ID: 10699610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravesical oxybutynin for spinal cord injury patients.
    Szollar SM; Lee SM
    Spinal Cord; 1996 May; 34(5):284-7. PubMed ID: 8963976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intravesical oxybutynin hydrochloride in the treatment of urge incontinence in the elderly].
    Mizunaga M; Miyata M; Kaneko S; Taniguchi N; Yachiku S; Chiba K; Osanai H; Fujisawa M
    Nihon Hinyokika Gakkai Zasshi; 1996 Jun; 87(6):923-7. PubMed ID: 8753011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin.
    Di Stasi SM; Giannantoni A; Navarra P; Capelli G; Storti L; Porena M; Stephen RL
    J Urol; 2001 Dec; 166(6):2232-6. PubMed ID: 11696741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary incontinence, hyperthermia, and sudden death.
    Herbst J; Gilbert JD; Byard RW
    J Forensic Sci; 2011 Jul; 56(4):1062-3. PubMed ID: 21470226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intravesical drug therapy in women with severe urge incontinence. Clinical experiences from a department of gynecology].
    Johansen JK; Lose G
    Ugeskr Laeger; 1999 Nov; 161(44):6052-5. PubMed ID: 10778341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical treatment of bladder dysfunction.
    Zimmern P
    J Urol; 2001 Dec; 166(6):2241. PubMed ID: 11696743
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
    Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
    Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of oxybutynin dependency.
    Guloksuz S; Eren K; Gurol DT
    Gen Hosp Psychiatry; 2010; 32(4):e5-6. PubMed ID: 20633735
    [No Abstract]   [Full Text] [Related]  

  • 35. Oxybutynin does not affect cyclosporin blood levels.
    Springate JE
    Ther Drug Monit; 2001 Apr; 23(2):155-6. PubMed ID: 11294516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics of intravesical and oral oxybutynin chloride.
    Massad CA; Kogan BA; Trigo-Rocha FE
    J Urol; 1992 Aug; 148(2 Pt 2):595-7. PubMed ID: 1640530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of neurogenic bladder dysfunction in infants and children with neurospinal dysraphism with clean intermittent (self)catheterisation and optimized intravesical oxybutynin hydrochloride therapy.
    Buyse G; Verpoorten C; Vereecken R; Casaer P
    Eur J Pediatr Surg; 1995 Dec; 5 Suppl 1():31-4. PubMed ID: 8770576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice.
    Movig KL; Egberts AC; Lenderink AW; Leufkens HG
    J Am Geriatr Soc; 2001 Feb; 49(2):234-5. PubMed ID: 11207885
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic use of oxybutynin and spinal anesthesia: a case of postoperative urinary retention and hematuria.
    Hobaika AB
    Middle East J Anaesthesiol; 2011 Oct; 21(3):431-2. PubMed ID: 22428504
    [No Abstract]   [Full Text] [Related]  

  • 40. Oxybutynin dosage questioned.
    Faller NA
    J ET Nurs; 1992; 19(5):190. PubMed ID: 1420535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.